首页> 美国卫生研究院文献>PLoS Clinical Trials >Insertion of an intrathecal catheter in parturients reduces the risk of post-dural puncture headache: A retrospective study and meta-analysis
【2h】

Insertion of an intrathecal catheter in parturients reduces the risk of post-dural puncture headache: A retrospective study and meta-analysis

机译:产前插入鞘内导管降低了硬膜后穿刺性头痛的风险:一项回顾性研究和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to determine whether insertion of an intrathecal catheter following accidental dural puncture (ADP) in obstetric patients can reduce the incidence of post-dural puncture headache (PDPH) and the requirement of a therapeutic epidural blood patch (TEBP). This was also compared with relocating the epidural catheter at a different vertebral interspace. A retrospective study was performed, as well as a meta-analysis of the literature to further validate our findings. We reviewed the records of 86 obstetric patients who suffered from ADP during epidural anesthesia or combined spinal-epidural anesthesia from October 2015 to November 2016 at our institution. Although, there was no significant decrease in the incidence of PDPH (P = 0.08), the requirement for a TEBP (P = 0.025) was significantly reduced in the intrathecal catheter group compared with the relocated group. In the meta-analysis, 13 eligible studies including 1044 obstetric patients were finally identified. To estimate the pooled risk ratios (RRs), fixed or random effect models were used depending on the heterogeneity. We initially found that an intrathecal catheter significantly reduced the incidence of PDPH (pooled RR = 0.823; 95% CI = 0.700–0.967; P = 0.018) and the requirement of a TEBP (pooled RR = 0.616; 95% CI = 0.443–0.855; P = 0.004). Our study shows that insertion of an intrathecal catheter following ADP might be an effective and dependable method for reducing the risk of a PDPH and requirement for a TEBP in obstetric patients.
机译:这项研究旨在确定产科患者意外硬脑膜穿刺(ADP)后插入鞘内导管是否可以减少硬脑膜穿刺后头痛(PDPH)的发生率和治疗性硬膜外补血片(TEBP)的需求。这也与将硬膜外导管移至不同椎间隙处进行了比较。进行了回顾性研究以及文献的荟萃分析,以进一步验证我们的发现。我们回顾了2015年10月至2016年11月在硬膜外麻醉或脊柱-硬膜外联合麻醉期间患有ADP的86例产科患者的记录。尽管PDPH的发生率没有显着降低(P = 0.08),但是鞘内导管组的TEBP需求量(P = 0.025)与重新安置的组相比明显减少。在荟萃分析中,最终确定了13项合格研究,其中包括1044例产科患者。为了估计风险汇总率,根据异质性使用固定或随机效应模型。我们最初发现鞘内导管可显着降低PDPH的发生率(合并的RR = 0.823; 95%CI = 0.700–0.967; P = 0.018)和需要TEBP(合并的RR = 0.616; 95%CI = 0.443-0.855)。 ; P = 0.004)。我们的研究表明,在ADP后插入鞘内导管可能是降低产科患者PDPH风险和TEBP需求的有效且可靠的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号